🇺🇸 FDA
Patent

US 10300043

Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof

granted A61KA61K2035/115A61K31/405

Quick answer

US patent 10300043 (Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof) held by The Regents of the University of California expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2035/115, A61K31/405, A61K35/74, A61K35/741